If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
Trulicity ® (dulaglutide) injection
0.75 mg/0.5 mL, 1.5 mg/0.5 mL, 3mg/0.5mL, 4.5mg/0.5mL
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
TRULICITY® (dulaglutide): QTC Interval
At supratherapeutic doses (4 and 7 mg), dulaglutide does not prolong QTc.
The effect of dulaglutide on cardiac repolarization was thoroughly tested in a QTc study and found that at supratherapeutic doses, dulaglutide 4 mg and dulaglutide 7 mg did not prolong QTc.1
Enclosed Prescribing Information
1Trulicity [package insert]. Indianapolis, IN: Eli Lilly and Company; 2021.
QTc = corrected QT interval
Date of Last Review: January 03, 2020